{"id":149185,"date":"2026-07-13T15:10:44","date_gmt":"2026-07-13T09:40:44","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=149185"},"modified":"2026-07-13T15:10:45","modified_gmt":"2026-07-13T09:40:45","slug":"rpg-life-sciences-share-price-archerchem-naprosyn-launch","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/","title":{"rendered":"RPG Life Sciences Share Price Touches 52-Week High as Company Partners With Archerchem for Naprosyn ES Launch"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>RPG Life Sciences partners with Archerchem Healthcare to launch Naproxen and Esomeprazole combination Naprosyn ES for the first time in India. Stock touches 52-week high of Rs 2,950, up 0.79%.<\/em><\/p>\n<p>The RPG Life Sciences share price touched a fresh 52-week high on Monday, 13 July 2026, in a session marked by broad-based buying interest in the counter, after the pharmaceutical company announced a partnership with Archerchem Healthcare to launch a Naproxen and Esomeprazole combination product, branded Naprosyn ES, for the first time in the Indian market.<\/p>\n<p>The launch strengthens <a href=\"https:\/\/univest.in\/stocks\/rpglife\/rpg-life-sciences-ltd-share-price-today\">RPG Life Sciences<\/a>&#8216;s existing business relationship with Archerchem Healthcare. The RPG Life Sciences stock was quoting at Rs 2,877.00, up Rs 22.50 or 0.79 percent, after touching an intraday high of Rs 2,950.00, matching its 52-week high, before easing slightly to a low of Rs 2,820.45 during the session.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#RPG_Life_Sciences_Share_Price_Naprosyn_ES_Launch_Details\" title=\"RPG Life Sciences Share Price: Naprosyn ES Launch Details\">RPG Life Sciences Share Price: Naprosyn ES Launch Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#Why_the_Archerchem_Partnership_Matters_for_the_RPG_Life_Sciences_Share_Price\" title=\"Why the Archerchem Partnership Matters for the RPG Life Sciences Share Price\">Why the Archerchem Partnership Matters for the RPG Life Sciences Share Price<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#1_First-to-Market_Combination_Product\" title=\"1. First-to-Market Combination Product\">1. First-to-Market Combination Product<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#2_Strengthening_an_Existing_Business_Relationship\" title=\"2. Strengthening an Existing Business Relationship\">2. Strengthening an Existing Business Relationship<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#3_Addressing_an_Underserved_Pain_Management_Segment\" title=\"3. Addressing an Underserved Pain Management Segment\">3. Addressing an Underserved Pain Management Segment<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#What_Should_Investors_Watch_in_the_RPG_Life_Sciences_Share_Price_Now\" title=\"What Should Investors Watch in the RPG Life Sciences Share Price Now\">What Should Investors Watch in the RPG Life Sciences Share Price Now<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#Frequently_Asked_Questions_FAQs\" title=\"Frequently Asked Questions FAQs\">Frequently Asked Questions FAQs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#Why_did_the_RPG_Life_Sciences_share_price_hit_a_52-week_high_today\" title=\"Why did the RPG Life Sciences share price hit a 52-week high today?\">Why did the RPG Life Sciences share price hit a 52-week high today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#What_is_Naprosyn_ES\" title=\"What is Naprosyn ES?\">What is Naprosyn ES?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#Who_is_RPG_Life_Sciences_partnering_with_for_this_launch\" title=\"Who is RPG Life Sciences partnering with for this launch?\">Who is RPG Life Sciences partnering with for this launch?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#How_much_did_the_RPG_Life_Sciences_share_price_gain_today\" title=\"How much did the RPG Life Sciences share price gain today?\">How much did the RPG Life Sciences share price gain today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#Why_is_a_combination_product_like_Naprosyn_ES_significant\" title=\"Why is a combination product like Naprosyn ES significant?\">Why is a combination product like Naprosyn ES significant?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/rpg-life-sciences-share-price-archerchem-naprosyn-launch\/#Should_investors_buy_RPG_Life_Sciences_after_this_52-week_high\" title=\"Should investors buy RPG Life Sciences after this 52-week high?\">Should investors buy RPG Life Sciences after this 52-week high?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"RPG_Life_Sciences_Share_Price_Naprosyn_ES_Launch_Details\"><\/span><strong>RPG Life Sciences Share Price: Naprosyn ES Launch Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The combination of Naproxen, a widely used non-steroidal anti-inflammatory drug, with Esomeprazole, a proton pump inhibitor that helps protect the stomach lining, addresses a common clinical need for pain management with reduced gastrointestinal risk. Fixed-dose combinations of the RPG Life Sciences share price growth story typically require less time for physicians to prescribe confidently, since the gastroprotective component is already built into the formulation rather than requiring a separate prescription and patient compliance for a second medication.<\/p>\n<table>\n<thead>\n<tr>\n<th>Parameter<\/th>\n<th>Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Partner<\/td>\n<td>Archerchem Healthcare<\/td>\n<\/tr>\n<tr>\n<td>Product<\/td>\n<td>Naprosyn ES, a Naproxen and Esomeprazole combination<\/td>\n<\/tr>\n<tr>\n<td>Market status<\/td>\n<td>First-time launch in India<\/td>\n<\/tr>\n<tr>\n<td>Current price<\/td>\n<td>Rs 2,877.00 (+0.79%)<\/td>\n<\/tr>\n<tr>\n<td>52-week high<\/td>\n<td>Rs 2,950.00 (touched intraday)<\/td>\n<\/tr>\n<tr>\n<td>Intraday low<\/td>\n<td>Rs 2,820.45<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Trading volumes for the RPG Life Sciences share price stood at 3,302 shares against the five-day average of 3,828 shares, a decrease of 13.74 percent, indicating the positive reaction has been steady rather than driven by an unusually large surge in institutional buying.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_the_Archerchem_Partnership_Matters_for_the_RPG_Life_Sciences_Share_Price\"><\/span><strong>Why the Archerchem Partnership Matters for the RPG Life Sciences Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_First-to-Market_Combination_Product\"><\/span><strong>1. First-to-Market Combination Product<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Launching a Naproxen and Esomeprazole combination for the first time in India gives RPG Life Sciences an early-mover advantage in this specific therapeutic combination, which can support premium pricing and brand loyalty before competitors introduce similar formulations. First-mover status in a specific combination category can be particularly valuable in the Indian pharmaceutical market, where physician prescribing habits, once established, tend to be sticky and can create a durable moat against later entrants.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Strengthening_an_Existing_Business_Relationship\"><\/span><strong>2. Strengthening an Existing Business Relationship<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The company specifically noted this launch strengthens its existing relationship with Archerchem Healthcare, suggesting a track record of successful collaboration that could pave the way for further joint product launches in the future, further supporting the broader product pipeline narrative behind the RPG Life Sciences share price story.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Addressing_an_Underserved_Pain_Management_Segment\"><\/span><strong>3. Addressing an Underserved Pain Management Segment<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Combination products that pair an anti-inflammatory with gastric protection address a genuine clinical gap, since NSAID use is often limited by gastrointestinal side effects. Products that mitigate this risk while retaining efficacy can capture meaningful share in the broader pain management category. Chronic pain conditions, including arthritis and musculoskeletal disorders, often require prolonged NSAID use, making gastric protection a meaningful clinical consideration rather than a marginal add-on feature for many patients.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Get Pharmaceutical Sector Stock Guidance from a SEBI-Registered Investment Advisor<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Should_Investors_Watch_in_the_RPG_Life_Sciences_Share_Price_Now\"><\/span><strong>What Should Investors Watch in the RPG Life Sciences Share Price Now<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors tracking the RPG Life Sciences share price should watch the initial market uptake of Naprosyn ES over the coming quarters, along with any expansion of the product into additional dosage forms or therapeutic line extensions that could broaden its addressable market within India&#8217;s pain management segment.<\/p>\n<p>Given that the stock touched a fresh 52-week high on this news, investors should also watch whether the RPG Life Sciences share price can sustain above this level in subsequent sessions, since a failure to hold new highs can sometimes trigger short-term profit booking from investors who bought into the initial rally. Historically, stocks that break out to new highs on genuine business catalysts, rather than pure speculation, tend to hold their gains better than those driven by short-term momentum alone.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track the RPG Life Sciences share price live and get daily stock recommendations.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>RPG Life Sciences&#8217; new partnership with Archerchem Healthcare to launch Naprosyn ES, a first-of-its-kind Naproxen and Esomeprazole combination in India, has pushed the RPG Life Sciences share price to a fresh 52-week high of Rs 2,950.00 today. The launch further reinforces the company&#8217;s product pipeline and its existing partner relationships in the pharmaceutical space. Investors should track early product uptake and consult a SEBI-registered advisor before making investment decisions.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_FAQs\"><\/span><strong>Frequently Asked Questions FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_the_RPG_Life_Sciences_share_price_hit_a_52-week_high_today\"><\/span><strong>Why did the RPG Life Sciences share price hit a 52-week high today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The RPG Life Sciences share price touched a 52-week high of Rs 2,950.00 after the company announced a partnership with Archerchem Healthcare to launch Naprosyn ES, a Naproxen and Esomeprazole combination, for the first time in India.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Naprosyn_ES\"><\/span><strong>What is Naprosyn ES?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Naprosyn ES is a combination product of Naproxen, an anti-inflammatory drug, and Esomeprazole, a proton pump inhibitor that helps protect the stomach lining, being launched for the first time in the Indian market.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Who_is_RPG_Life_Sciences_partnering_with_for_this_launch\"><\/span><strong>Who is RPG Life Sciences partnering with for this launch?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> RPG Life Sciences is partnering with Archerchem Healthcare to launch Naprosyn ES, strengthening its existing business relationship with the company.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_the_RPG_Life_Sciences_share_price_gain_today\"><\/span><strong>How much did the RPG Life Sciences share price gain today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The RPG Life Sciences share price gained 0.79 percent to Rs 2,877.00, after touching an intraday high of Rs 2,950.00, matching its 52-week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_a_combination_product_like_Naprosyn_ES_significant\"><\/span><strong>Why is a combination product like Naprosyn ES significant?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Combination products pairing an anti-inflammatory drug with gastric protection address a common clinical need, since NSAID use is often limited by gastrointestinal side effects.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_investors_buy_RPG_Life_Sciences_after_this_52-week_high\"><\/span><strong>Should investors buy RPG Life Sciences after this 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should track early product uptake and whether the stock sustains above its new high, and consult a SEBI-registered investment advisor before making investment decisions.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why did the RPG Life Sciences share price hit a 52-week high today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The RPG Life Sciences share price touched a 52-week high of Rs 2,950.00 after the company announced a partnership with Archerchem Healthcare to launch Naprosyn ES, a Naproxen and Esomeprazole combination, for the first time in India.\"}},{\"@type\":\"Question\",\"name\":\"What is Naprosyn ES?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Naprosyn ES is a combination product of Naproxen, an anti-inflammatory drug, and Esomeprazole, a proton pump inhibitor that helps protect the stomach lining, being launched for the first time in the Indian market.\"}},{\"@type\":\"Question\",\"name\":\"Who is RPG Life Sciences partnering with for this launch?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"RPG Life Sciences is partnering with Archerchem Healthcare to launch Naprosyn ES, strengthening its existing business relationship with the company.\"}},{\"@type\":\"Question\",\"name\":\"How much did the RPG Life Sciences share price gain today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The RPG Life Sciences share price gained 0.79 percent to Rs 2,877.00, after touching an intraday high of Rs 2,950.00, matching its 52-week high.\"}},{\"@type\":\"Question\",\"name\":\"Why is a combination product like Naprosyn ES significant?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Combination products pairing an anti-inflammatory drug with gastric protection address a common clinical need, since NSAID use is often limited by gastrointestinal side effects.\"}},{\"@type\":\"Question\",\"name\":\"Should investors buy RPG Life Sciences after this 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should track early product uptake and whether the stock sustains above its new high, and consult a SEBI-registered investment advisor before making investment decisions.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RPG Life Sciences share price touches a 52-week high of Rs 2,950 on 13 July 2026 after partnering with Archerchem Healthcare to launch Naprosyn ES, a Naproxen and Esomeprazole combination, for the first time in India.<\/p>\n","protected":false},"author":34,"featured_media":149210,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[4133],"class_list":["post-149185","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-52-week-high"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1783935650:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_title":["RPG Life Sciences Share Price Hits 52-Week High"],"rank_math_description":["RPG Life Sciences share price touches a 52-week high of Rs 2,950 on 13 July 2026 after partnering with Archerchem Healthcare to launch Naprosyn ES in India."],"rank_math_focus_keyword":["RPG Life Sciences share price"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["149210"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["25792"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/banner-44.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/149185","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=149185"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/149185\/revisions"}],"predecessor-version":[{"id":149212,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/149185\/revisions\/149212"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/149210"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=149185"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=149185"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=149185"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}